• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION SYNVISC; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION SYNVISC; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number 50208
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Pain (1994); Swelling (2091); Skin Inflammation (2443)
Event Date 08/21/2003
Event Type  Injury  
Event Description
About 12 hours after injection, he had swelling, warmth, and severe pain in his knees to the point that he was unable to ambulate.The severe pain lasted approximately 1.5 days, but the swelling remained a week later.This happened with the first two injections after having had several rounds of three injections weekly without any adverse reaction; biomatrix / wyeth.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
GENZYME CORPORATION
MDR Report Key10829253
MDR Text Key216191760
Report NumberMW5097795
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Physician
Type of Report Initial
Report Date 08/29/2003
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date05/01/2005
Device Lot Number50208
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age69 YR
Patient Weight108
-
-